His average price was $1.72 so it must have occurred recently although the date field on the form was blank. Explains the recent drop.Seems to be no need to panic and sell on this news. Should recover back to at least the 1.70's.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
